Founded by Dr. Pete Coelho and led by Peter David, MedicalCue has developed a bedside tablet computer system that guides medical teams during newborn resuscitation. Much like a GPS offering real-time traffic avoidance, the startup's technology provides dynamic,...
Search Results
Hospitals Need to Treat Neonatal Resuscitation Like a Formula One Car Race
One of my favorite things to do at the Fogarty Institute is visit the Fog Shop, where our medtech startups brainstorm innovative solutions to solve some of the most critical health problems. Not only are these entrepreneurs a great source of inspiration, but they...
New Device Shows Strong Promise to Solve Common Childbirth-Related Injuries
Giving birth to a child is perhaps one of the most anticipated, happiest and most celebrated moments of a woman's life. Unfortunately, it is also one of the toughest physical stressors on a woman's body. Surprisingly, it has not received a lot of attention – until...
InterVene Sets Off to New Zealand For Early Feasibility Clinical Trials
One of our recent graduates, InterVene, is making great strides, having recently been approved and funded to do early feasibility clinical trials in New Zealand. The team, led by founder and CEO Fletcher Wilson, left right before Labor Day Weekend. InterVene has...
About the New Startups
Igantia Therapeutics, a health and research company, is developing a first-of-its-kind medical device and digital health technology for the treatment and study of an age-related ailment that affects most women – hot flashes. Madorra is developing the first,...
Congratulations Graduates, Welcome New Companies-in-Residence
The Fogarty Institute for Innovation is proud to continue to strengthen its presence in women"s healthcare innovation, with the addition of three new startups, which have joined the organization as new companies-in-residence: Igantia Therapeutics, Marz Medical...
Our Companies
Jessie Becker, co-founder and CEO of InPress Technologies, and Surbhi Sarna, founder and CEO of nVision Medical, both made the Forbes "30 Under 30" list. Our companies-in-residence make incredible strides in advancing medical technology on a daily basis and it is...
HeartFlow sets the gold standard for diagnosing coronary artery disease
HeartFlow, Inc. the Institute's first company-in-residence and graduate, is changing the way that patients with suspected coronary artery disease (CAD) are managed. Affecting 16.8 million Americans, CAD develops when the coronary arteries are narrowed, reducing blood...
Don’t Sweat It: Fogarty Company Palmm Uses Innovative Technology to Address Excessive Sweating Condition
Justin Huelman knows that sweaty palms aren't just an annoyance to be wiped away. As someone who has suffered from excessive sweating, technically known as hyperhidrosis, since his youth, he was motivated to find a solution. That's what led him to co-found palmm, one...
Fogarty Institute adds four new startups; two companies graduate
Following a very competitive application process, the Fogarty Institute is excited to welcome four new startups to its incubator program: Healyx, palmm, Radial Medical and Raydiant Oximetry. The companies were selected based on their proven experience in the space,...